These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 33543577)

  • 1. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
    Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
    Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Medicine (Baltimore); 2016 Jan; 95(3):e2272. PubMed ID: 26817863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
    Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
    Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new magnetic resonance imaging tumour response grading scheme for locally advanced rectal cancer.
    Pang X; Xie P; Yu L; Chen H; Zheng J; Meng X; Wan X
    Br J Cancer; 2022 Jul; 127(2):268-277. PubMed ID: 35388140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
    Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer.
    Jäger T; Neureiter D; Urbas R; Klieser E; Hitzl W; Emmanuel K; Dinnewitzer A
    Dis Colon Rectum; 2017 Aug; 60(8):815-826. PubMed ID: 28682967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
    Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
    Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs.
    Tang YL; Li DD; Duan JY; Wang X
    Int J Colorectal Dis; 2024 Jun; 39(1):93. PubMed ID: 38896374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
    Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
    Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.
    He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB
    Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer.
    Mace AG; Pai RK; Stocchi L; Kalady MF
    Dis Colon Rectum; 2015 Jan; 58(1):32-44. PubMed ID: 25489692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
    Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
    Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
    Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
    Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective study of role of neoadjuvant rectal scores in evaluating the 10-year disease-free survival of patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy followed by surgery].
    Zhang WL; Zhou C; Wang WF; Li WH; He JH; Lu ZH; Wu XJ; Lin JZ; Peng JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jun; 27(6):608-614. PubMed ID: 38901994
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Oncotarget; 2016 Feb; 7(5):6335-44. PubMed ID: 26695441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.
    Trakarnsanga A; Gönen M; Shia J; Nash GM; Temple LK; Guillem JG; Paty PB; Goodman KA; Wu A; Gollub M; Segal N; Saltz L; Garcia-Aguilar J; Weiser MR
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25249540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.